Roth Capital Partners will host its 5th Annual Healthcare Opportunities Conference on Sept. 29, 2026, at the Metropolitan Club in New York City, the investment bank announced. The invitation-only event will bring together C-suite executives from more than 30 public healthcare companies and leading institutional investors for a day of one-on-one and small-group meetings.
The conference will feature companies representing biotechnology, life science tools and diagnostics, and medical technology. In addition to the private meetings, the event will include discussions on neuroscience, drug pricing and coverage, regulatory uncertainty and capital constraints in biotechnology, and minimal residual disease (MRD) monitoring in solid tumors.
The event will be hosted by ROTH senior healthcare research analysts Jonathan Aschoff, Ph.D., Max Masucci, Boobalan Pachaiyappan, Ph.D., and Adam Walsh, MD. Their involvement underscores the firm’s commitment to providing institutional investors with direct access to industry leaders and actionable insights.
Since 2010, ROTH has been involved in more than 600 transactions for healthcare clients representing more than $25 billion in total transaction value. This track record positions the conference as a significant gathering for stakeholders seeking to navigate the complex healthcare investment landscape.
The timing of the conference is notable as the healthcare sector faces evolving policy debates, scientific breakthroughs, and funding challenges. By facilitating dialogue between executives and investors, the event aims to uncover opportunities and address critical issues shaping the future of healthcare innovation.
For those interested in attending or learning more about the full calendar of events, additional details are available at https://ibn.fm/vDTjP.
ROTH is a relationship-driven investment bank focused on serving growth companies and their investors. Its full-service platform spans capital raising, high-impact equity research, macroeconomics, sales and trading, technical insights, derivatives strategies, M&A advisory, and corporate access. Headquartered in Newport Beach, California, ROTH is a privately held, employee-owned firm with offices across the U.S. For more information, visit www.roth.com.
The announcement was distributed through InvestorWire, a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. InvestorWire is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers access to a vast network of wire solutions, article and editorial syndication to 5,000+ outlets, enhanced press release enhancement, social media distribution via IBN to millions of social media followers, and a full array of tailored corporate communications solutions.
With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists, and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content, and actionable information converge. For more information, please visit https://www.InvestorWire.com. Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer.
